688617 惠泰医疗
已收盘 12-05 15:00:00
资讯
新帖
简况
11月26日惠泰医疗现5笔大宗交易 机构净买入503.94万元
证券之星 · 11-26
11月26日惠泰医疗现5笔大宗交易 机构净买入503.94万元
每周股票复盘:惠泰医疗(688617)取得栓塞微球注册证
证券之星 · 11-23
每周股票复盘:惠泰医疗(688617)取得栓塞微球注册证
惠泰医疗(688617)公司公告董事会换届选举结果,11月21日股价下跌0.9%
证券之星 · 11-21
惠泰医疗(688617)公司公告董事会换届选举结果,11月21日股价下跌0.9%
惠泰医疗(688617.SH)子公司取得一项医疗器械注册证
智通财经网 · 11-18
惠泰医疗(688617.SH)子公司取得一项医疗器械注册证
惠泰医疗(688617)披露参加2025年度深圳辖区上市公司投资者网上集体接待日活动安排,11月14日股价下跌1.69%
证券之星 · 11-14
惠泰医疗(688617)披露参加2025年度深圳辖区上市公司投资者网上集体接待日活动安排,11月14日股价下跌1.69%
锦江电子重启IPO辅导:“终止历史”何以凭空清零?
华尔街见闻 · 11-14
锦江电子重启IPO辅导:“终止历史”何以凭空清零?
惠泰医疗(688617)披露董事会换届选举候选人名单,11月12日股价上涨0.75%
证券之星 · 11-12
惠泰医疗(688617)披露董事会换届选举候选人名单,11月12日股价上涨0.75%
迈瑞医疗:2024年新增经销商较多因惠泰医疗纳入报表
证券之星 · 11-12
迈瑞医疗:2024年新增经销商较多因惠泰医疗纳入报表
每周股票复盘:惠泰医疗(688617)将召开股东会并举行业绩说明会
证券之星 · 11-09
每周股票复盘:惠泰医疗(688617)将召开股东会并举行业绩说明会
惠泰医疗(688617)披露关于召开2025年第三次临时股东会的通知,11月05日股价上涨5.42%
证券之星 · 11-05
惠泰医疗(688617)披露关于召开2025年第三次临时股东会的通知,11月05日股价上涨5.42%
惠泰医疗:董事会换届选举
证券日报网 · 11-05
惠泰医疗:董事会换届选举
股市必读:惠泰医疗(688617)股东户数0.57万户,较上期增加26.25%
证券之星 · 10-27
股市必读:惠泰医疗(688617)股东户数0.57万户,较上期增加26.25%
国金证券:给予惠泰医疗买入评级
证券之星 · 10-26
国金证券:给予惠泰医疗买入评级
惠泰医疗(688617)2025年三季报简析:营收净利润同比双双增长
证券之星 · 10-26
惠泰医疗(688617)2025年三季报简析:营收净利润同比双双增长
每周股票复盘:惠泰医疗(688617)Q3营收同比增长24.77%
证券之星 · 10-26
每周股票复盘:惠泰医疗(688617)Q3营收同比增长24.77%
惠泰医疗最新公告:前三季度净利润同比增长18.02%
证券之星 · 10-24
惠泰医疗最新公告:前三季度净利润同比增长18.02%
惠泰医疗涨6.86%,太平洋三周前给出“买入”评级
证券之星 · 09-24
惠泰医疗涨6.86%,太平洋三周前给出“买入”评级
每周股票复盘:惠泰医疗(688617)专注主业拓展海外市场
证券之星 · 09-21
每周股票复盘:惠泰医疗(688617)专注主业拓展海外市场
股市必读:惠泰医疗(688617)9月18日披露最新机构调研信息
证券之星 · 09-19
股市必读:惠泰医疗(688617)9月18日披露最新机构调研信息
每周股票复盘:惠泰医疗(688617)现5.37亿元折价大宗交易
证券之星 · 09-14
每周股票复盘:惠泰医疗(688617)现5.37亿元折价大宗交易
加载更多
公司概况
公司名称:
深圳惠泰医疗器械股份有限公司
所属行业:
专用设备制造业
上市日期:
2021-01-07
主营业务:
深圳惠泰医疗器械股份有限公司的主营业务是电生理和介入类医疗器械的研发、生产和销售。公司的主要产品是电生理、冠脉通路、外周血管介入、非血管介入医疗器械。电生理电极标测导管、射频消融电极导管均为国内首家获得注册证的国产产品,同时被科技部认定为国家重点新产品、被深圳科工贸信委认定为深圳市自主创新产品。射频消融导管被广东省科技厅认定为高新技术产品。公司的漂浮临时起搏电极导管为该类别国内首个获得注册证的国产产品。
发行价格:
74.46
{"stockData":{"symbol":"688617","market":"SH","secType":"STK","nameCN":"惠泰医疗","latestPrice":241.41,"timestamp":1764918000000,"preClose":241.82,"halted":0,"volume":852790,"delay":0,"changeRate":-0.0017,"floatShares":141000000,"shares":141000000,"eps":5.4479,"marketStatus":"已收盘","change":-0.41,"latestTime":"12-05 15:00:00","open":242.42,"high":244,"low":236.68,"amount":204000000,"amplitude":0.0303,"askPrice":241.41,"askSize":9,"bidPrice":241.39,"bidSize":7,"shortable":0,"etf":0,"ttmEps":5.4479,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"adjPreClose":241.82,"symbolType":"stock_kcb","openAndCloseTimeList":[[1764898200000,1764905400000],[1764910800000,1764918000000]],"highLimit":266,"lowLimit":217.64,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":141030049,"isCdr":false,"pbRate":11.39,"roa":"--","peRate":44.312487,"roe":"22.41%","epsLYR":6.96,"committee":-0.213115,"marketValue":34046000000,"turnoverRate":0.006,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-12-08。","afterMarket":{"amount":0,"volume":0,"close":241.41,"buyVolume":0,"sellVolume":0,"time":1764920037768,"indexStatus":"已收盘 12-05 15:30:00","preClose":241.82},"floatMarketCap":34046000000},"requestUrl":"/m/hq/s/688617","defaultTab":"news","newsList":[{"id":"2586258555","title":"11月26日惠泰医疗现5笔大宗交易 机构净买入503.94万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586258555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586258555?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:52","pubTimestamp":1764150753,"startTime":"0","endTime":"0","summary":"证券之星消息,11月26日惠泰医疗发生大宗交易,交易数据如下:近三个月该股共发生7笔大宗交易,合计成交2.89万手,折价成交7笔。该股近期无解禁股上市。截至2025年11月26日收盘,惠泰医疗报收于241.95元,下跌1.88%,换手率1.72%,成交量2.43万手,成交额5.85亿元。该股近半年内有股东持股变动,合计净增持282.03万股,股东增减持明细如下表:该股最近90天内共有13家机构给出评级,买入评级11家,增持评级2家;过去90天内机构目标均价为363.54。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"gpt_icon":0},{"id":"2585103223","title":"每周股票复盘:惠泰医疗(688617)取得栓塞微球注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2585103223","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585103223?lang=zh_cn&edition=full","pubTime":"2025-11-23 02:57","pubTimestamp":1763837829,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘,惠泰医疗报收于259.0元,较上周的274.28元下跌5.57%。本周,惠泰医疗11月17日盘中最高价报276.0元。2025年第三次临时股东会决议公告深圳惠泰医疗器械股份有限公司于2025年11月21日召开2025年第三次临时股东会,审议通过董事会换届选举议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"gpt_icon":0},{"id":"2585314994","title":"惠泰医疗(688617)公司公告董事会换届选举结果,11月21日股价下跌0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585314994","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585314994?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:29","pubTimestamp":1763735358,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘,惠泰医疗报收于259.0元,较前一交易日下跌0.9%,最新总市值为365.23亿元。该股当日开盘260.88元,最高262.22元,最低256.27元,成交额达2.78亿元,换手率为0.76%。近日,惠泰医疗发布2025年第三次临时股东会决议公告。公告显示,公司于2025年11月21日召开2025年第三次临时股东会,审议通过了董事会换届选举议案。出席会议股东所持表决权占公司总表决权的59.3046%,所有议案均获通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100040237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"gpt_icon":0},{"id":"2584498403","title":"惠泰医疗(688617.SH)子公司取得一项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2584498403","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584498403?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:16","pubTimestamp":1763453815,"startTime":"0","endTime":"0","summary":"智通财经APP讯,惠泰医疗(688617.SH)公告,公司全资子公司湖南埃普特医疗器械有限公司取得一项医疗器械注册证,产品名称为聚乙烯醇栓塞微球。该产品适用于富血管型实质型器官恶性肿瘤的栓塞治疗。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1370485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688617","09997","BK1574","BK1100","BK0251","BK1583","159883","BK1222","09996"],"gpt_icon":0},{"id":"2583200502","title":"惠泰医疗(688617)披露参加2025年度深圳辖区上市公司投资者网上集体接待日活动安排,11月14日股价下跌1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583200502","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583200502?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:46","pubTimestamp":1763131584,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,惠泰医疗报收于274.28元,较前一交易日下跌1.69%,最新总市值为386.77亿元。该股当日开盘279.0元,最高280.38元,最低274.28元,成交额达1.39亿元,换手率为0.36%。近日,惠泰医疗发布公告称,公司将于2025年11月20日14:30-17:00通过网络远程方式参加由深圳证监局和中证中小投资者服务中心指导、深圳上市公司协会与深圳市全景网络有限公司联合举办的“2025年度深圳辖区上市公司投资者网上集体接待日活动”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400042109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"gpt_icon":0},{"id":"2583750593","title":"锦江电子重启IPO辅导:“终止历史”何以凭空清零?","url":"https://stock-news.laohu8.com/highlight/detail?id=2583750593","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583750593?lang=zh_cn&edition=full","pubTime":"2025-11-14 20:36","pubTimestamp":1763123786,"startTime":"0","endTime":"0","summary":"日前,四川锦江电子医疗器械科技股份有限公司(下称“锦江电子”)向证监局递交了IPO辅导备案申请。\n这...","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"https://wallstreetcn.com/articles/3759412","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3759412","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688617"],"gpt_icon":0},{"id":"2582282377","title":"惠泰医疗(688617)披露董事会换届选举候选人名单,11月12日股价上涨0.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582282377","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582282377?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:30","pubTimestamp":1762957840,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘,惠泰医疗报收于285.13元,较前一交易日上涨0.75%,最新总市值为402.07亿元。该股当日开盘282.12元,最高287.88元,最低281.6元,成交额达1.81亿元,换手率为0.45%。近日,惠泰医疗发布2025年第三次临时股东会会议资料,宣布将审议董事会换届选举事项。上述候选人任期三年,均符合董事任职资格,未持有公司股份,与公司不存在关联关系,未受过行政处罚或被认定为不适合担任董事的情形。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"gpt_icon":0},{"id":"2582243783","title":"迈瑞医疗:2024年新增经销商较多因惠泰医疗纳入报表","url":"https://stock-news.laohu8.com/highlight/detail?id=2582243783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582243783?lang=zh_cn&edition=full","pubTime":"2025-11-12 17:42","pubTimestamp":1762940530,"startTime":"0","endTime":"0","summary":"证券之星消息,迈瑞医疗(300760)11月12日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,请问迈瑞医疗港交所上市说明书中披露:2024年新增经销商3371家。这个幅度比历年高出一倍,请问是什么原因?谢谢迈瑞医疗回复:您好,谢谢关注。2024年新增经销商较多的原因是惠泰医疗纳入报表导致。谢谢。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200029154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["IE0031814852.USD","LU2488822045.USD","LU0605514214.HKD","LU0405327148.USD","LU0823426480.USD","LU1688375341.USD","LU1979443071.USD","LU1997245094.SGD","LU1720050803.USD","688617","LU0823426308.USD","LU1064131003.USD","LU0359202008.SGD","LU2213484517.USD","LU1580142542.USD","LU0572944931.SGD","LU2153591404.USD","SGXZ49509284.SGD","IE0008368742.USD","LU1734074674.USD","LU1794554557.SGD","LU0327786744.USD","LU2153592121.USD","LU0594300419.USD","LU1023057109.AUD","IE00B031HY20.USD","LU2348773727.SGD","LU1997245177.USD","LU0084288322.USD","LU1064130708.USD","LU1820825898.SGD","LU2424517915.HKD","BK0251","LU2148510915.USD","IE00B29SXG58.USD","LU1655091616.SGD","LU2348774022.SGD","LU0650527681.SGD","LU1146622755.USD","IE00B031J352.USD","LU1934453819.USD","SGXZ81163826.USD","300760","IE0005HP3H50.USD","LU0594300179.USD","LU0405327494.USD","LU1781817850.SGD","LU0359201612.USD"],"gpt_icon":0},{"id":"2582861811","title":"每周股票复盘:惠泰医疗(688617)将召开股东会并举行业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861811","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861811?lang=zh_cn&edition=full","pubTime":"2025-11-09 03:33","pubTimestamp":1762630392,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘,惠泰医疗报收于283.5元,较上周的276.0元上涨2.72%。本周关注点来自公司公告汇总:惠泰医疗将于2025年11月21日召开第三次临时股东会,审议董事会换届事项。公司公告汇总深圳惠泰医疗器械股份有限公司将于2025年11月21日召开2025年第三次临时股东会,现场会议时间为当日9点30分,地点为上海市徐汇区田林路487号宝石园20栋宝石大厦22楼会议室。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"gpt_icon":0},{"id":"2581768267","title":"惠泰医疗(688617)披露关于召开2025年第三次临时股东会的通知,11月05日股价上涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581768267","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581768267?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:26","pubTimestamp":1762352787,"startTime":"0","endTime":"0","summary":"截至2025年11月5日收盘,惠泰医疗报收于290.33元,较前一交易日上涨5.42%,最新总市值为409.41亿元。该股当日开盘277.7元,最高293.5元,最低274.02元,成交额达4.19亿元,换手率为1.04%。公司近日发布公告称,深圳惠泰医疗器械股份有限公司将于2025年11月21日召开2025年第三次临时股东会,现场会议时间为当日9点30分,地点为上海市徐汇区田林路487号宝石园20栋宝石大厦22楼会议室。股权登记日为2025年11月17日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500040751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"gpt_icon":0},{"id":"2581977604","title":"惠泰医疗:董事会换届选举","url":"https://stock-news.laohu8.com/highlight/detail?id=2581977604","media":"证券日报网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581977604?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:09","pubTimestamp":1762351740,"startTime":"0","endTime":"0","summary":"证券日报网讯11月5日晚间,惠泰医疗发布公告称,公司董事会同意提名葛昊先生、李新胜先生、赵云女士、赵宇翔先生、成正辉先生为公司第三届董事会非独立董事候选人,同意提名孙乐非先生、李光先生、白云霞女士为公司第三届董事会独立董事候选人,其中白云霞女士为会计专业人士。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-05/doc-infwkiit6406269.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-05/doc-infwkiit6406269.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688617","BK0251"],"gpt_icon":0},{"id":"2578654896","title":"股市必读:惠泰医疗(688617)股东户数0.57万户,较上期增加26.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578654896","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578654896?lang=zh_cn&edition=full","pubTime":"2025-10-27 03:01","pubTimestamp":1761505275,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,惠泰医疗报收于324.0元,下跌1.22%,换手率0.74%,成交量1.04万手,成交额3.43亿元。股本股东变化股东户数变动截至2025年9月30日公司股东户数为5690.0户,较6月30日增加1183.0户,增幅为26.25%。公司公告汇总2025年第三季度报告深圳惠泰医疗器械股份有限公司2025年第三季度报告未经审计。关于增加2025年度日常关联交易预计的公告公司拟增加2025年度日常关联交易预计金额合计1,862.00万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700000763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"gpt_icon":0},{"id":"2578431689","title":"国金证券:给予惠泰医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2578431689","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578431689?lang=zh_cn&edition=full","pubTime":"2025-10-26 08:50","pubTimestamp":1761439829,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,何冠洲近期对惠泰医疗进行研究并发布了研究报告《收入端高速增长,研发投入显著提升》,给予惠泰医疗买入评级。 盈利预测、估值与评级 预计公司2025-2027年归母净利润分别为8.20、10.34、13.18亿元,同比+22%、+26%、+27%,现价对应PE为56、44、35倍,维持“买入”评级。最新盈利预测明细如下:该股最近90天内共有14家机构给出评级,买入评级12家,增持评级2家;过去90天内机构目标均价为364.14。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600002837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617"],"gpt_icon":0},{"id":"2578836756","title":"惠泰医疗(688617)2025年三季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2578836756","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578836756?lang=zh_cn&edition=full","pubTime":"2025-10-26 06:07","pubTimestamp":1761430030,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期惠泰医疗发布2025年三季报。根据财报显示,惠泰医疗营收净利润同比双双增长。截至本报告期末,公司营业总收入18.67亿元,同比上升22.47%,归母净利润6.23亿元,同比上升18.02%。持有惠泰医疗最多的基金为长盛医疗量化股票A,目前规模为1.32亿元,最新净值2.1792,较上一交易日上涨0.27%,近一年上涨19.01%。公司2025年半年度报告已于2025年8月22日在上海证券交易所网站正式披露,2025年第三季度报告将于2025年10月按照相关法规要求披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617"],"gpt_icon":0},{"id":"2578044445","title":"每周股票复盘:惠泰医疗(688617)Q3营收同比增长24.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578044445","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578044445?lang=zh_cn&edition=full","pubTime":"2025-10-26 02:36","pubTimestamp":1761417371,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,惠泰医疗报收于324.0元,较上周的307.71元上涨5.29%。本周,惠泰医疗10月24日盘中最高价报337.2元。惠泰医疗当前最新总市值456.88亿元,在医疗器械板块市值排名4/126,在两市A股市值排名385/5160。业绩披露要点:2025年第三季度营业收入6.54亿元,同比增长24.77%。股本股东变化截至2025年9月30日,惠泰医疗股东户数为5690户,较6月30日增加1183户,增幅26.25%。公司公告汇总深圳惠泰医疗器械股份有限公司拟增加2025年度日常关联交易预计金额合计1,862.00万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617"],"gpt_icon":0},{"id":"2577512560","title":"惠泰医疗最新公告:前三季度净利润同比增长18.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577512560","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577512560?lang=zh_cn&edition=full","pubTime":"2025-10-24 21:48","pubTimestamp":1761313722,"startTime":"0","endTime":"0","summary":"惠泰医疗(688617.SH)公告称,公司第三季度营业收入6.54亿元,同比增长24.77%;净利润1.98亿元,同比增长6.77%。前三季度营业收入18.67亿元,同比增长22.47%;净利润6.23亿元,同比增长18.02%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400041766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617"],"gpt_icon":0},{"id":"2569573779","title":"惠泰医疗涨6.86%,太平洋三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2569573779","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569573779?lang=zh_cn&edition=full","pubTime":"2025-09-24 16:26","pubTimestamp":1758702394,"startTime":"0","endTime":"0","summary":"今日惠泰医疗涨6.86%,收盘报321.65元。2025年8月29日,太平洋研究员谭紫媚,李啸岩发布了对惠泰医疗的研报《惠泰医疗:业绩符合预期,看好PFA全年快速放量》,该研报对惠泰医疗给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为87.53%。此外,华安证券研究员谭国超,李婵,东吴证券研究员朱国广近期也对该股发布了研报,同样给出“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092400028422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","688617"],"gpt_icon":0},{"id":"2569245284","title":"每周股票复盘:惠泰医疗(688617)专注主业拓展海外市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2569245284","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569245284?lang=zh_cn&edition=full","pubTime":"2025-09-21 03:31","pubTimestamp":1758396673,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘,惠泰医疗报收于300.99元,较上周的300.08元上涨0.3%。本周,惠泰医疗9月18日盘中最高价报308.47元。惠泰医疗当前最新总市值424.44亿元,在医疗器械板块市值排名4/126,在两市A股市值排名407/5153。关于成正辉先生未来的具体持股情况,若发生相关变动,公司将严格按照相关法规要求及时履行信息披露义务。惠泰的下一个五年计划正在制定中,我们的目标是在成为心血管领域国际领先企业前每年维持一个较快的增速。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"gpt_icon":0},{"id":"2568028424","title":"股市必读:惠泰医疗(688617)9月18日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2568028424","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568028424?lang=zh_cn&edition=full","pubTime":"2025-09-19 01:17","pubTimestamp":1758215831,"startTime":"0","endTime":"0","summary":"截至2025年9月18日收盘,惠泰医疗报收于303.75元,上涨0.7%,换手率0.94%,成交量1.33万手,成交额4.05亿元。来自机构调研要点:成正辉先生减持系个人资金需求,不涉及对公司发展或与迈瑞融合前景的看空。公司2025年半年度报告已于8月22日披露,第三季度报告将于2025年10月按法规要求披露,当前经营一切正常。成正辉先生目前仍持有公司股份,并任副董事长及总经理,深度参与公司战略与运营;后续若持股变动将依规披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900000961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688617","BK0251"],"gpt_icon":0},{"id":"2567818135","title":"每周股票复盘:惠泰医疗(688617)现5.37亿元折价大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2567818135","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567818135?lang=zh_cn&edition=full","pubTime":"2025-09-14 03:13","pubTimestamp":1757790789,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘,惠泰医疗报收于300.08元,较上周的309.44元下跌3.02%。本周,惠泰医疗9月8日盘中最高价报321.99元。交易信息汇总9月11日惠泰医疗发生1笔折价19.81%的大宗交易,合计成交金额5.37亿元。股本股东变化股东增减持9月11日,惠泰医疗股东深圳迈瑞科技控股有限责任公司通过大宗交易增持公司股份216.47万股,占总股本1.5351%。减持后其持股比例由18.70%降至16.70%,权益变动触及1%刻度。增持后其持股比例由21.52%升至23.05%,与一致行动人合计持股达26.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400000659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688617"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765007623329,"stockEarnings":[{"period":"1week","weight":0.0312},{"period":"1month","weight":-0.1685},{"period":"3month","weight":-0.2198},{"period":"6month","weight":-0.1077},{"period":"1year","weight":-0.0688},{"period":"ytd","weight":-0.0558}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳惠泰医疗器械股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"5690人(较上一季度增加26.25%)","perCapita":"24785股","listingDate":"2021-01-07","address":"广东省深圳市南山区西丽街道松坪山社区松坪山朗山路11号同方信息港B栋601","registeredCapital":"14103万元","survey":" 深圳惠泰医疗器械股份有限公司的主营业务是电生理和介入类医疗器械的研发、生产和销售。公司的主要产品是电生理、冠脉通路、外周血管介入、非血管介入医疗器械。电生理电极标测导管、射频消融电极导管均为国内首家获得注册证的国产产品,同时被科技部认定为国家重点新产品、被深圳科工贸信委认定为深圳市自主创新产品。射频消融导管被广东省科技厅认定为高新技术产品。公司的漂浮临时起搏电极导管为该类别国内首个获得注册证的国产产品。","listedPrice":74.46},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"惠泰医疗(688617)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供惠泰医疗(688617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"惠泰医疗,688617,惠泰医疗股票,惠泰医疗股票老虎,惠泰医疗股票老虎国际,惠泰医疗行情,惠泰医疗股票行情,惠泰医疗股价,惠泰医疗股市,惠泰医疗股票价格,惠泰医疗股票交易,惠泰医疗股票购买,惠泰医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"惠泰医疗(688617)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供惠泰医疗(688617)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}